ArticleFrontiers in oncology2024

Case report: Toripalimab plus anlotinib in postoperative recurrent renal pelvic sarcomatoid urothelial carcinoma.

Xinrong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.